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Abstract
The immunomodulatory power of heat-killed Gordonia bronchialis was studied on gut epithelial cells activated with
pro-inflammatory stimuli (flagellin, TNF-a or IL-1b). Light emission of luciferase-transfected epithelial cells and mRNA
expression of IL-1b, TNF-a, IL-6, CCL20, IL-8 and MCP-1 were measured. NF-kB activation was assessed by immuno-
fluorescence and immunoblotting, and induction of reactive oxygen species (ROS) was evaluated. In vivo inhibitory
properties of G. bronchialis were studied with ligated intestinal loop assay and in a mouse model of food allergy. G.
bronchialis promoted the down-regulation of the expression of CCL20 and IL-1b on activated epithelial cells in a dose-
dependent manner. A concomitant blocking of nuclear p65 translocation with increased production of ROS was found.
In vivo experiments confirmed the inhibition of CCL20 expression and the suppression of IgE sensitization and hyper-
sensitivity symptoms in the food allergy mouse model. In conclusion, heat-killed G. bronchialis inhibited the activation
of NF-kB pathway in human epithelial cells, and suppressed the expression of CCL20. These results indicate that
G. bronchialis may be used to modulate the initial steps of innate immune activation, which further suppress the allergic
sensitization. This approach may be exploited as a therapy for intestinal inflammation.
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Introduction
The intestinal immune system has to strike a delicate
balance between initiating an inflammatory response
against invading pathogens and preventing a reaction
against the microbiota that colonizes the lumen, includ-
ing innocuous Ags. Gut homeostasis involves an intri-
cate and not fully understood crosstalk between the
microbiota and the immune system. Intestinal epithelial
cells (IEC) play a key role in Ag sampling and modu-
lation of both the innate and adaptive immune response
to maintain a controlled inflammation. In this scenario,
inflammatory responses against bacterial invasion
result in the lumenal secretion of antimicrobial peptides
and the release of cytokines and chemokines to recruit
and activate different cell subsets. However, these
mechanisms, which are mediated by the NF-kB path-
way, are also induced in the aberrant immune response
(acute and chronic inflammation) observed in different
intestinal disorders, such as inflammatory bowel
diseases (IBD) and food allergy.1 In this study we
analyzed the role of heat-killed Gordonia bronchialis
on the modulation of activated epithelial cells (ECs),
through the down-regulation of the NF-kB signaling
pathway.
Among the aerobic Actinomycetales is a number of
genera containing species with remarkable immune-
modulating capacities. The first of these to be investi-
gated in recent times was Mycobacterium vaccae.
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This species and the closely related Mycobacterium
obuense are mycobacteria with immunoregulatory prop-
erties, including the down-regulation of Th2 mechan-
isms and the enhancing of Th1 response, thus
providing effective immunotherapeutic reagents.
Numerous studies with M. vaccae in humans have
shown beneficial effects in tuberculosis2 and leprosy;3
in allergies, such as asthma;4 autoimmune diseases,
such as psoriasis;5 and cancer.6 Over the last few years,
species from other genera have been recognized
as having similar immunomodulating properties.
Several of these non-mycobacterial species, notably
G. bronchialis, Rhodococcus coprophilus and
Tsukamurella inchonensis have been investigated in a
number of experimental and naturally-occurring condi-
tions in animals. In common with all the
Actinomycetales, Gordonia species possess powerful
cell wall-associated adjuvants and like those of
M. vaccae, adjuvants of G. bronchialis are immunomo-
dulatory. At least two activities on the immune response
have been described: immune modulation and suppres-
sion of inflammation.7
G. bronchialis is a Gram-positive, weakly acid-fast,
type species of the genus Gordonia within the sub-order
Corynebacteriaceae of the aerobic Actinomycetales. A
complete genome sequence of G. bronchialis is avail-
able8. It is an environmental organism that rarely
gives rise to human infections as a secondary pathogen
superimposed on preceding disease of various causes.9
Published studies with injected heat-killed
G. bronchialis and R. coprophilus show that they can
limit parasitaemia, and the development of chronic
focal myocarditis in an experimental rat model of
Trypanosoma cruzi infection,10 and they can limit
the development of myointimal hyperplasia following
balloon injury to the common carotid artery in another
rat model.11 These findings can be attributed to
immune modulation resulting from the effect of bacter-
ial adjuvants, combined with bacterial heat-shock pro-
teins that cross-react with mammalian proteins
expressed on stressed tissue. In spontaneously-occur-
ring diseases the beneficial effect of treatment with
Actinomycetales is seen in dogs with flea-bite allergy
and in horses with allergy to midge bites (sweet-
itch).12 In aquacultural medicine, oral administration
of G. bronchialis and T. inchonensis have shown major
benefits in larval survival, control of stress, and growth
rates in fishes and shrimps. Oral administration in
mammals has also proved successful, with good results
in the treatment of tuberculosis in humans with cap-
sules containing M. vaccae,13 and in horses with sweet-
itch using capsules containing T. inchonensis (J
Stanford, personal communication).
In this study we investigated whether anti-inflamma-
tory properties could be demonstrated in human and
mouse enterocytes exposed to heat-killed G. bronchialis.
Dead bacteria were used in vitro and in vivo to suppress
the early steps of inflammation through the modulation
of IEC, which are heavily involved in the recruitment of
immune cells and the induction of the immune
response. A question that still awaits answer is whether
the effect applies only to acute inflammation in the




Heat-killed, borate-buffered, aerobic G. bronchialis
were provided by BioEos (Marden, UK) as BE-G101.
The samples, generated from Ag-free Sauton’s medium
and prepared as described previously,8 were provided
as autoclaved suspensions in borate-buffered saline pH
8 at a concentration of 10mg wet mass (equivalent to
1010) of organisms per ml. All G. bronchialis treatments
in the study were with the homogenized sample, and the
numbers refer to the original bacterial numbers esti-
mated for that sample.
Cell culture
Human colon carcinoma cell lines Caco-2 and Caco-2-
luciferase (Caco-luc) (Caco-2 cell line transfected with
pccl20 Luc plasmid)14were employed. In Caco-luc cells
the luciferase expression is under the control of the
CCL20 promoter, which, in turn, is controlled through
different NF-kB binding sites. All cells were grown in
DMEM supplemented with 10% FBS, 100 U/ml peni-
cillin and 100mg/ml streptomycin. Incubations were
carried out at 37C in a humidified atmosphere contain-
ing 5% CO2. ECs were cultured with flagellin (FliC)
from Salmonella Typhimurium (1mg/ml), recombinant
human TNF-a (rhTNF-a 10 ng/ml; R&D,
Minneapolis, USA) or IL-1b (10 ng/ml; R&D).
Reporter gene expression assays
Caco-luc cells were pre-incubated with G. bronchialis
(1 109 bacteria/well) or with sulfasalazine [1 and
10 mM sulfasalazine (SSZ)] (Sigma-Aldrich, St. Louis,
MO, USA) for 30min and then stimulated with FliC,
TNF-a or IL-1b for 6 h at 37C in complete
DMEM medium. Cells were treated with lysis buffer
(25 mM Tris-phosphate, 2mM DTT, 2mM 1,2-diami-
nocyclohexane-N,N,N0,N0-tetraacetic acid, 10% gly-
cerol and 1% Triton X-100) and luciferase activity
was measured using the luciferase substrate (luciferase
assay kit; Promega, Madison, WI, USA) following the
manufacturer’s instructions. Light emission was mea-
sured with a luminometer (Luminoscan TL Plus;
Labsystem, Jerusalem, Israel). The relative luciferase
activity was determined as the ratio of treated/
untreated cell activities.
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Caco-luc cells were pre-incubated with Man (man-
nose) (0.1–500mM), or a Man receptor-specific Ab
(BioLegend, San Diego, CA, USA), and G. bronchialis
(1 109 bacteria) for 30min. Then cells were activated
with FliC for 6 h and light emission was evaluated.
Western blotting
Cytoplasmatic and nuclear extracts were obtained from
Caco-2 cells that were pre-incubated with G. bronchialis
for 30min and then stimulated with FliC or medium as
control for 90min. Cells were harvested and lysed with
10mM HEPES, 1.5mM MgCl2, 10mM KCl and 0.1%
Nonidet P-40 in the presence of a protease inhibitor
mixture (Sigma-Aldrich). After spinning, the cytoplas-
mic extract was stored at –80C until used and nuclear
pellets were treated with 10mM HEPES, 1.5mM
MgCl2, 0.2mM, EDTA and 20% glycerol. The soluble
fraction was mixed with 10mM Tris-HCl, 60mM KCl,
10% glycerol, 0.25mM EDTA and 0.125mM EGTA.
The amount of protein was determined by bicinchoni-
nic acid assay (Pierce, Rockford, IL, USA). Protein
samples were resolved on 10% SDS-PAGE under redu-
cing conditions (BioRad Mini-Protean III; BioRad,
Richmond, CA, USA), and transferred onto a nitrocel-
lulose membrane for 1 h at 300mA. Blots were blocked
and probed with a rabbit anti-p65 or a mouse anti-pIkB
Ab (Santa Cruz, Santa Cruz, CA, USA), followed by
the appropriate HRP-conjugated secondary Ab
(BioRad). Protein bands were visualized by enhanced
chemiluminescence (ECL Plus; GE Healthcare, Bucks,
UK) according to the manufacturer0s instructions.
Blots were stripped and incubated with a rabbit anti-
human histone H3 or b-actin Ab (AbCam, Cambridge,
UK) diluted 1:1000 and 1:3000, respectively, as an
internal loading control. The bands were scanned and
quantified using Adobe Photoshop CS software.
Quantitative real time RT-PCR
Caco-2 cells were incubated for 2 h with FliC (1 mg/ml),
rhTNF-a (10 ng/ml) or IL-1b (10 ng/ml) alone or pre-
treated with G. bronchialis (1 109 bacteria/well) for
30min and then stimulated. Cells were collected and
total RNA was isolated using the illustra RNAspin
mini isolation kit according the manufacture’s specifi-
cations (GE Healthcare, Freiburg, Germany). The
quality of the extracted RNA was determined by UV
absorption and the OD ratio of OD280nm/OD260nm was
used as a purity marker. A cDNA preparation was
obtained from 1 mg of RNA using Moloney Murine
Leukemia Virus (M-MLV) reverse transcriptase and
random primers (Invitrogen, Life Technologies,
Carlsbad, CA, USA). Cytokine and chemokine
mRNA expression was determined by real-time quan-
titative PCR. The experimental procedure was per-
formed with the ABI PRISM sequence detection
system using SYBRGreen fluorescence (BioRad). The
sequences of the primers were designed with the
Perlprimer software using nucleotide sequences present
in a GeneBank database. b-Actin was used as a house-
keeping gene to standardize the total amount of cDNA;
the genes of interest were chemokine ligand-20 (CCL20),
IL-8, monocyte chemotactic protein-1 (MCP-1), IL-6,
TNF- and IL-1. Relative mRNA levels (2Cts) were
determined by comparing the PCR cycle threshold
between cDNA of the gene of interest and that of b-
actin (Cts), and comparing Cts values between the trea-
ted and untreated condition (Cts).
ELISA assay for CCL20 quantification
Confluent Caco-2 cells grown on 48-well plates were
incubated with G. bronchialis for 30min and then sti-
mulated with FliC (1mg/ml) for 24 h. Supernatant was
collected and processed for CCL20 quantification by
ELISA, according to the manufacturer’s instructions
(Human CCL20 ELISA kit; R&D).
Microscopy techniques
Caco-2 cells (1 106 cells/well) were grown in a mono-
layer and then incubated with G. bronchialis (1 109
bacteria/well) for 30min, followed by exposure to
FliC (1mg/ml) for 2 h. Washed Caco-2 cells were fixed
in 2% glutaraldehyde in PBS (pH 7.4) and dehydrated
in an ethanol series. For scanning electron microscopy
(SEM) cells were coated with gold (15–20 nm) and sam-
ples were analyzed with a Philips SEM 505 microscope.
Transmission electronic microscopy (TEM) was carried
out according to the method described by Hayat.15
Cells were treated with 1% osmium tetroxide to pro-
vide contrast to the image, embedded in epoxy resin
and cut into thin sections (90 nm). Finally, samples
were treated with uranyl acetate and lead acetate, and
then examined in a JEM-1200EX Mark II (JEOL Ltd,
Tokyo, Japan) transmission electron microscope.
For fluorescence microscopy cells grown on glass
slides were fixed with 4% paraformaldehyde in PBS
(pH 7.4), and permeabilized with 0.1% Triton in PBS.
Non-specific binding sites were blocked with 2%
BSA for 30min, and then cells were incubated with
rabbit anti-p65 (Santa Cruz) diluted 1:25 for 60min at
room temperature, followed by an anti-rabbit
Alexa488 conjugated secondary Ab (Invitrogen,
Carlsbad, CA, USA). Propidium iodide (1 mg/ml) was
used as a counterstain. An SP5 Leica confocal micro-
scope was used and images were analyzed with
LAS AF Lite software (Leica, Wetzlar, Germany).
Immunofluorescense microscopy for reactive oxygen
species (ROS) assay was done with ECs incubated with
G. bronchialis (1 109 bacteria/well), H2O2 (1mM),
butyrate (5mM) or Hanks buffered saline
solution (HBSS) for 30min. Then, cells were washed
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and incubated in the dark with 3.5 mM of 5-(and 6-)
chloromethyl-20,70-dichlorodihydro-fluorescein diace-
tate, acetyl ester (CM-H2DCFDA) (Invitrogen)
for 15min. To evaluate if antioxidants could block
ROS generation, cells were pretreated with 20mM N-
acetylcysteine (NAC) (Sigma-Aldrich) or the NADPH
oxidase inhibitor 10 mM diphenyleneiodonium (DPI)
(Sigma-Aldrich) for 30min before incubation with
G. bronchialis. Images were acquire using Nikon
Eclipse Ti-U microscope (Nikon, Tokyo, Japan).
Image acquisition and processing
Fluorescence images were acquired using the NIS-
Elements F (Nikon), and Image J software was used
to merge the different pictures. Confocal images were
acquired using the LAS AF Lite software (Leica). The
SEM images were automatically transferred during
examination using the Scandium SEM Imaging
Platform (Olympus, Münster, Germany). TEM
images were acquired and processed using the Gatan
Digital Micrograph software with an ES1000W
Erlanghshen CCM Camera (Model 785). Finally,
TIFF images were obtained using Adobe Photoshop
CS3 software.
In vivo inhibitory effect of G. bronchialis in the gut
Male Balb/c mice, 6–8-wks old, 25–30 g of mass (pur-
chased from the School of Animal Science, University of
La Plata, La Plata, Argentina), were fasted for 2 h and
anaesthetized by i.p. injection of ketamine (100mg/kg)
and xylacine (5mg/kg). Two ligated loops of the small
intestine were made per mouse, as described else-
where,16 and mice were kept anesthetized during the
experiment. A suspension of G. bronchialis (109 bac-
teria/150 ml) in saline solution was injected into the
lumen alone or with FliC (250mg). Saline solution or
FliC was also injected in individual loops, as negative
and positive controls, respectively. Two h later mice
were killed by cervical dislocation. Loops were collected
and washed with saline buffer, Peyer’s patches were dis-
sected off and the tissue was homogenized in lysis buffer.
Total RNA was isolated and CCL20 gene expression
was assessed as previously described. The fold change
was defined as the ratio of the normalized values corres-
ponding to loops filled with G. bronchialis, FliC, or G.
bronchialis and FliC to that filled with saline.
Inhibition of gut inflammation induced by gavage
with cholera toxin in mice
Male 6–8-wk-old Balb/c mice were maintained with
water and a commercial diet provided ad libitum.
Animals received on consecutive days five intragastric
doses of a suspension of G. bronchialis (1 109 bacteria/
200 ml) and then were sensitized by gavage with 10 mg of
cholera toxin (CT; Sigma-Aldrich) on three consecutive
days. Mice were fasted for 2 h, and received 3% sodium
bicarbonate solution to reduce stomach acidity 30min
before the administration. Two h after the last admin-
istration, animals were killed by cervical dislocation and
the gut was excised.
A piece of jejunum was collected, Peyer’s patches
were dissected off, and the tissue was washed with
PBS and then homogenized in lysis buffer. To isolate
IEC the jejunum was washed, opened longitudinally
and incubated for 10min at 4C in buffer A (HBSS
supplemented with 100 IU/ml penicillin, 100mg/ml
streptomycin and 2% equine serum) with 1 mM
DTT. Then, the tissue was incubated with fresh buffer
A plus 0.5mM EDTA for 20min at 37C with vigorous
shaking. Supernatant containing ECs was collected,
centrifuged and immediately re-suspended in RPMI
supplemented with 5% FBS, penicillin/streptomycin
and gentamicin. Total RNA was isolated from the
entire tissue, or IEC using the RNA extraction kit,
and the gene expression was assessed as previously
described.
Intragastric immunomodulation with
G. bronchialis in a cow’s milk protein food
allergy mouse model
Six 8-wk-old mice were sensitized with six weekly intra-
gastric doses of 20mg of cow’s milk protein (CMP) plus
10 mg of CT in a final volume of 200 ml of bicarbonate
buffer (sensitized mice), as described previously.17 To
modulate the allergic sensitization, mice received
1 109 bacteria of G. bronchialis in 200 ml by the oral
route twice a week, for 5 wk. As controls, naı̈ve mice
received six weekly intragastric doses of 20mg CMP
without CT (sham control). Ten d after the last boost
mice were challenged by gavage with 20mg CMP.
Blood samples were collected during the sensitization
phase and sera were stored at –20C until used.
Twenty-four h after the oral challenge animals were
sacrificed by cervical dislocation, and spleens and jeju-
num were collected.
Levels of serum specific IgE Abs were measured
by EAST using cyanogen bromide-activated cellulose
paper disks coupled with CMP (1.75mg/ml) and devel-
oped essentially as described previously17. To study T
cell activation, cytokines were measured in super-
natants of Ag-stimulated splenocytes. Briefly, 24 h
after the oral challenge mice were killed, spleens were
resected and spleen cells were stimulated for 72 h with
CMP (350mg/ml). Production of IL-5 and IFN-g
(Invitrogen) was assayed by ELISA following manufac-
turer’s instructions.
The allergic status of animals was evaluated
in vivo by scoring symptoms following the oral chal-
lenge (30–60min), according to Table 1, in a blinded
fashion by two independent investigators.
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Statistical analysis
All statistical analyses were carried out using GraphPad
Prism 5 software. The significance of the difference was
determined using an independent-sample t-test or
ANOVA. A P-value< 0.05 was regarded as statistically
significant.
Results
G. bronchialis inhibits the flagellin-induced
luciferase activity and NF-B-dependent CCL20
production
Initially, we investigated whether G. bronchialis exerts
biological effects on human ECs. Colonic Caco-2 cells
transfected with pNF-kB Luc plasmid on a CCL20 pro-
moter (Caco-luc) were activated for 6 h with flagellin
(FliC), live or dead Salmonella Typhimurium and
dead G. bronchialis. Only FliC and Salmonella-induced
cell activation (Figure 1a). In order to determine if Gb
exerted any inhibitory effect on activated cells, endo-
thelial cells (EC) were pre-incubated with heat-killed
G. bronchialis and then exposed to different pro-inflam-
matory stimuli (FliC, IL1-b or TNF-a). We observed a
statistically significant inhibition of cell activation and
secretion of CCL20 in pre-treated cells in a dose-
response manner (Figure 1b–d). A significant inhibition
of activated cells (P< 0.01) was observed with 1000:1
and 10:1 bacteria:cell ratios.
The involvement of NF-kB on cell activation was
assessed using SSZ, and we found a complete abroga-
tion of Caco-luc activation when cells were pre-treated
with 10 mM SSZ and then stimulated (Figure 2a). To
further investigate if G. bronchialis exerts an inhibitory
effect on EC activation through blocking the NF-kB
pathway, the translocation of p65 into the nucleus
was analyzed by immunoblotting (Figure 2b) and con-
focal microscopy (Figure 2C). The pre-treatment of
FliC-activated cells with G. bronchialis modulated the
translocation of the NF-kB component. In resting cells,
p65 was retained in the cytosol (Figure 2 ci), while the
incubation of cells with FliC induced a more pro-
nounced fluorescence within the nucleus (Figure 2cii),
thus indicating the nuclear translocation of p65 as a
consequence of NF-kB activation. The low nuclear
fluorescence observed in cells pre-treated with
G. bronchialis indicated that translocation of p65 was
controlled (Figure 2ciii). A similar effect was observed
by immunoblotting (Figure 2b) with a fainter band cor-
responding to p65 in the nuclear extract of treated cells
compared with activated cells. The analysis of p-IkB by
immunoblotting revealed that G. bronchialis blocked
the phosphorylation of this inhibitory component of
the NF-kB pathway (Figure 2b). These results demon-
strate that dead G. bronchialis exerts an inhibitory effect
via suppression of phosphorylation of p-IkB with the
subsequent blocking of p65 translocation onto the
nucleus.
G. bronchialis contact generates the production
of ROS in Caco-2 cells
Evidence is accumulating that ROS are produced in
response to bacteria to maintain gut epithelial homeo-
stasis.18 We investigated if cells respond to contact
with G. bronchialis by ROS production. Resting
Caco-2 cells rapidly produced ROS upon incuba-
tion with dead G. bronchialis (H2O2 and butyrate
were employed as controls for ROS production)
(Figure 3a), and we observed that both G. bronchialis
and H2O2 completely abrogated the luciferase activity
in FliC-activated Caco-luc cells (Figure 3b). Then,
antioxidant drugs were employed to confirm this
effect (Figure 3a). Resting EC treated with the
NADPH oxidase inhibitorDPI or with the ROS scav-
enger NAC, and then incubated with G. bronchialis,
did not generate ROS and reversed the inhibitory
effect that Gb exerted on activated cells (Figure 3a,
b). These results additionally demonstrate that resting
EC express surface receptors that interact with dead
bacteria to induce the production of ROS responsible
for NF-kB inhibition.
The inhibitory effect exerted by G. bronchialis
is mediated by cell–bacteria contact and is
independent of phagocytosis
We showed by electron microscopy that dead
G. bronchialis is not phagocytised by ECs. All forms
Table 1. Clinical scores assigned to symptoms triggered following the oral challenge.
Score Symptoms
0 No symptoms
1 Scratching and rubbing around the snout and head
2 Puffiness around the eyes and mouth, pilo-erection, reduced activity and/or decreased activity with increased respiratory
rate
3 Respiratory distress, cyanosis around snout and tail
4 No activity upon stimuli, convulsion
5 Death
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of microscopy showed that bacteria are attached to
the cell surface and no bacteria could be intracellularly
evidenced. Figure 4 (a, b) shows that bacteria can either
be found free or in cluster only in activated cells, with a
typical bacillus shape of the order Actinomycetales.
Attachment of G. bronchialis to Caco-2 cells was stu-
died by electron microscopy. Of note, membrane pro-
trusions of ECs trapping bacilli could be seen by SEM
(Figure 4b).
Based on the information that the G. bronchialis
envelope contains lipoarabinomannans,19 we studied
the involvement of carbohydrates in cell:bacteria
interactions. Caco-luc cells were pre-incubated with
different concentration of Man, followed by incubation
with G. bronchialis and FliC. We found a Man dose-
dependent reversion of the inhibition exerted by G.
bronchialis (Figure 4c). Besides, blocking the Man
receptor with a specific Ab reverted the inhib-
ition promoted by G. bronchialis in activated
cells (Figure 4d). Overall, the inhibitory effect of
G. bronchialis on colonic EC is dependent neither
on bacterial viability nor on the presence of released
components of the cell wall, and the Man receptor
might be implicated in suppression.
G. bronchialis inhibits the induction of cytokine
and chemokine mRNA expression
Different cytokines and chemokines released by intest-
inal EC are involved in the early activation of innate
immunity. To study and quantify the inhibitory effect
ofG. bronchialis on the gene-transcription of pro-inflam-
matory mediators, we analyzed the gene expression pat-
tern of Caco-2 cells. Cells were treated with different
stimuli (FliC, IL-1 b and TNF-a) with or without
G. bronchialis for 2 h. A differential induction of
mRNA expression corresponding to IL-1,
IL-6, TNF-,CCL20, IL-8 andMCP-1 upon incubation
with the different stimuli was observed (Figure 5A, B).
Stimulation with FliC and IL-1b caused significant
induction of CCL20 (4530-fold and 1940-fold, respect-
ively) and TNF- (20.2-fold and 5.6-fold, respectively)
compared with untreated cells.We also found that TNF-
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Figure 1. Inhibitory effect of Actinomycetales on activated ECs. (a) Caco-luc cells (1 106 cells/well) were incubated with flagellin
(FliC, 1mg/ml), heat-killed S. Typhimurium or G. bronchialis (Gb), or live S. Typhimurium (1 107 bacteria/well) for 6 h and light
emission was measured. (b) Caco-luc cells were incubated with G. bronchialis (1 107 bacteria/well) for 30 min and then exposed to IL-
1b (10 ng/ml), FliC (1mg/ml) or TNF-a (10 ng/ml) for 6 h. Light emission was measured. (c) Caco-luc cells were incubated with different
quantities of G. bronchialis (bacteria:cell ratio is indicated) and then activated with FliC for 6 h. Light emission was measured. Results are
expressed as relative light emission of cells incubated with stimulus versus medium. Data are expressed as mean values of luciferase
activity SEM. (d) Cells were incubated with G. bronchialis for 30 min and then activated with FliC for 24 h. Supernatants were
evaluated for CCL20 concentration by ELISA. Results are representative of at least three independent experiments. *P< 0.05,
**P< 0.01, ***P< 0.005.
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Consistent with previous results G. bronchialis did
not activate resting ECs. We observed a differential
modulation of cytokine and chemokine gene expression
depending on the inflammatory stimulus with 1 109
bacteria (Figures 5c–f). When EC were pre-treated with
G. bronchialis for 30min and then stimulated with FliC
for 2 h we found a significant down-modulation of
mRNA expression of CCL20 (P< 0.01) and IL-8
(P< 0.005), with a decrease in IL-1 and IL-6.
Furthermore, when G. bronchialis-pre-treated cells
were activated with IL-1b, a significant suppression of
mRNA expression corresponding to CCL20 (P< 0.05)
and TNF- (P< 0.01) was observed, with a decrease in
IL-1 and IL-6. The gene expression of MCP-1 was not
modified with bacteria incubation.
G. bronchialis promotes in vivo inhibition of
CCL20 gene expression in the gut of Balb/c mice
To study the physiologic relevance of the gene tran-
scription suppression promoted by G. bronchialis, we
performed duodenal intralumenal injection of FliC,
G. bronchialis, FliC plus G. bronchialis or saline in dif-
ferent ligated intestinal loops in the small bowel of
Balb/c mice. The CCL20 mRNA expression in the
whole tissue was quantified and we found a statistically
significant inhibition of gene expression with a suspen-
sion of 1 109G. bronchialis compared with loops filled
with FliC (Figure 6a) (P< 0.01). As expected, loops
filled with G. bronchialis alone showed no induction
of CCL20 gene expression. This clearly suggests that
G. bronchialis does not activate mucosal cells, whereas
FliC-activated cells can be influenced in vivo by the
presence of heat-killed G. bronchialis.
Given the selective inhibition of cytokine and che-
mokine gene expression, we then sought to examine the
effect of G. bronchialis in a different pro-inflammatory
mucosal setting. Balb/c mice received five doses of a
suspension of G. bronchialis by gavage, followed by
three doses of CT intragastrically on separate days.
CCL20, MCP-1 and IL-1 mRNA expression was ana-
lyzed in the jejunum and in isolated enterocytes. We
observed that the CT-driven inflammation of the gut













































































































Figure 2. Modulatory effect of Actinomycetales on NF-kB activation. FliC-activated Caco-luc cells (1 106cells/well) were
pre-treated with 1 or 10mM of SSZ and light emission was measured. Results are expressed as relative light emission of treated
cells versus untreated cells (medium) (b) Caco-2 cells (1 106 cells/well) were incubated with FliC (1 mg/ml), FliC (1 mg/ml) plus
G. bronchialis (Gb) (1 109 bacteria/well) or medium for 90 min. The nuclear extract was obtained for detection of p65 and histone
H3 as internal control (left panel), and the cytoplasmic extract was used for detection of p-IB and b-actin as internal control
(right panel) by immunoblotting. (c) Caco-2 cells were grown in monolayer on glass slides and the presence of p65 was analyzed
by confocal microscopy using a rabbit anti-p65 primary Ab, followed by an anti-rabbit AlexaFluor 488-conjugated as secondary
Ab (green). Propidium iodide was used to stain the nucleus (red); (i) untreated cells (1 106 cells/well); (ii) cells (1 106/well)
activated with Flic (1mg/ml) for 90 min; (iii) Flic-activated cells with G. bronchialis (1 109 bacteria/well). Magnification 200.
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in the jejunum of treated animals, whereas MCP-1 was
only found increased in the whole tissue (Figure 6b).
Mice gavaged with G. bronchialis showed a more pro-
nounced inhibition of CCL20 gene expression
(P< 0.005) in enterocytes than in the jejunum tissue
(P< 0.01), whereas no modulation of MCP-1 gene
transcription was observed. CT also did not induce an
up-regulation of IL-1 gene expression. In conclusion,
CT-driven inflammation was modulated in vivo with
G. bronchialis intragastrically and enterocytes are the
main target cells for CCL20 modulation.
Finally, we used a food allergy mouse model
to evaluate the immunomodulatory capacity of
G. bronchialis in an Ag-dependent inflammatory condi-
tion. Orally-sensitized mice with CMP as allergen
plus CT as mucosal adjuvant,17 and simultaneously
treated with G. bronchialis intragastrically or saline
were challenged intragastrically with CMP to see if
symptoms were elicited upon exposition to the allergen
(Figure 6c). We observed that minutes after the oral
challenge sensitized animals treated with G. bronchialis
showed a lower clinical score than saline-treated sensi-
tized mice (Figure 6d). During the sensitization phase
CMP-specific IgE and IL-5 were induced in sensitized
mice, which reflects a CT-biased Th2-immune response
induction that led to allergic sensitization. The admin-
istration of G. bronchialis suppressed the oral sensitiza-
tion-promoted CMP-specific IgE by B cells (Figure 6e)
and IL-5 by splenocytes, while IFN-g remained
unchanged (Figure 6f). To characterize the mucosal
response IL-5, IFN-, Gata-3 and T-bet gene expression
was determined in jejunum lamina propria. We found a
reduction of IL-5 and Gata-3 gene expression in ani-
mals that received G. bronchialis orally (Figure 6g).
Overall, these results demonstrate that G. bronchialis
administration by the oral route modulates the innate
and adaptive immune response induced in the gut
mucosa, with a clear reduction of hypersensitivity
symptoms, serum-specific IgE level, systemic Th2-asso-
ciated cytokines and mucosal markers.
Discussion
IECs lining the gut have a critical role in the manage-
ment of exogenous Ags that contact the apical side
and the immune system through the basolateral side.
The intracellular signaling that is switched on or off in
these cells is intimately involved in the ability to balance
tolerance and protective immunity. In the present work
we studied the inhibitory effect that G. bronchialis
exerts on the human ileocecal epithelial carcinoma cell
line Caco-2. Several pro-inflammatory cytokines and
chemokines were induced in Caco-2 cells activated
in vitro with FliC, IL-1b or TNF-a. We have previously
studied the kinetics of cell activation and we found that
2 h after stimulation the mRNA corresponding to pro-
inflammatory mediators peaked (results not shown).
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Figure 3. Induction of ROS by G. bronchialis (Gb) and inhibition of Caco-luc cells. ROS were revealed by fluorescence micros-
copy with 5-(and 6)-chloromethyl-20,70-dichlorodihydro-fluorescein diacetate, acetyl ester (CM-H2DCFDA) (3.5 mM) on Caco-2 cells
incubated with PBS, G. bronchialis (1 109 bacteria/well), H2O2 (1 mM) and butyrate (5 mM), with and without the antioxidants DPI
(10 mM) and NAC (20 mM). Fluorescence images were acquired and processed. (B) Caco-luc cells (1 106 cells/well) were incubated
with G. bronchialis (1 109 bacteria/well) or H2O2 (1 mM) and the antioxidant NAC (20 mM) and then exposed to FliC. Light emission
was measured. All the results are representative of at least three independent experiments. *P< 0.05, **P< 0.01, ***P< 0.005.
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most potent activators for IEC, which reflects what is
already known about a higher expression of specific
receptors.20 Although it has been described that the
Caco-2 cell line constitutively expresses mRNA of
IL-1, IL-8 and MCP-1,21 these inflammatory medi-
ators were significantly up-regulated upon activation
(more than fourfold). Remarkably, CCL20, which
recruits immature dendritic cells and T lymphocytes
to mucosal target sites,22 showed the most significant
increase in activated cells (increase of more than 1800-
fold). These results suggest that the Caco-2 cell line
constitutes a useful mucosal EC line to study the
effect of different activators and modulators of the
immune response.23 In this study, we used dead G.
bronchialis to investigate the modulation of the early
steps of IEC activation. A clear in vivo and in vitro
inhibition of CCL20 gene expression was found,
which indicates that these bacteria may interfere with
the cell recruitment that mediates inflammation and
induction of innate and adaptive immune responses.
One of the central transcription factors that mediates
inflammatory responses is NF-kB.24 This family of
transcription factors is known to play a key role in
promoting the expression of cytokines and chemokines
through the interaction with different cofactors in the
nuclear gene promoter regions in response to enteric
microorganisms.25 All of the transcriptional responses
induced in Caco-2 cells with FliC, IL-1b or TNF-a are
initiated by NF-kB activation, with the phosphoryl-
ation of IkB kinases and the release of p65. The
former is degraded through the proteasome, and the
latter is translocated into the nucleus to bind specific
DNA sequences resulting in induction of gene expres-
sion of pro-inflammatory immune mediators.26 Our
study showed, for the first time, that the immunomo-
dulatory Actinomycetales have the ability to suppress
the pro-inflammatory NF-kB signaling activation,
which was indirectly evidenced through the modulation
of CCL20 gene expression and secretion. We found
that dead G. bronchialis induced the production of
ROS, which inhibited the phosphorylation of IkB,
and, hence, the translocation of p65 onto the
nucleus. Similar protective effects of ROS have been
















































Figure 4. Electron microscopy of Caco-2 cells with G. bronchialis (Gb). Resting or FliC-activated Caco-2 cells (1 106) were incu-
bated with heat-killed G. bronchialis (1 109 bacteria) for 2 h and analyzed by electron microscopy. (A) TEM of resting (left) and FliC-
activated cells (right). Arrows indicate bacteria adhered to membrane cells. Dead bacteria attached to the cell surface is depicted.
Original magnification, 12,000. (B) SEM of FliC-activated cells with bacteria attached. Magnifications of 5000 (left) and
10,000 (right). (C) Caco-luc cells (1 106 cells/well) were co-incubated with G. bronchialis (1 109/well), Man (0.1–500 mM) and FliC
(1mg/ml) for 6 h. Cells were lysed and light emission was measured. Results are expressed as relative light emission of treated cells to
cells incubated with medium. (D) FliC-Caco-luc activated cells were co-incubated with G. bronchialis and different concentrations of
the specific Ab to the Man receptor (a-MMR). Light emission was measured. Results are representative of at least three independent
experiments. *P< 0.05, **P< 0.01, ***P< 0.005.
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through the production of butyrate.18,23,27 We also
demonstrated that this inhibitory effect exerted by
G. bronchialis is not dependent on phagocytosis,
and Man-specific receptors on the membrane of IEC
could be implicated.
FliC used as cell stimulator mimics the scenario
of IBD,28,29 as bacterial flagellin from the microbiota
is a dominant Ag that activates innate immunity28
with an aberrant NF-kB activity and CCL20 over-
expression30. Dendritic cells and T cells that are con-
tinually attracted into the gut wall31 sustain the
increased levels of IL-1b and TNF-a, which mediate
the intestinal inflammation.32 Therefore, the in vitro
conditions here used to activate colonic ECs may repre-
sent the mucosal condition of gastrointestinal inflam-
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Figure 6. In vivo modulation of CCL20 mRNA expression and treatment of a food allergy mouse model. (a) The lumen of intes-
tinal loops in Balb/c mice were injected with G. bronchialis (1 109 bacteria/200 ml), FliC (250 mg), G. bronchialis (Gb) and FliC, or
saline and left for 2 h in anesthetized animals. Excised jejunum was analyzed for CCL20 mRNA induction. -Actin gene expression
was used to normalize the amount of cDNA. Results are expressed as fold change in mRNA expression SEM comparing the
standardized amount of cDNA corresponding to the loops filled with G. bronchialis, FliC or G. bronchialis and FliC to that of
saline. Results are representative of three independent experiments. (b) Balb/c mice were gavaged with CT (10mg) and then with
G. bronchialis (1 109 bacteria/mouse). Cytokine and chemokine mRNA expression was analyzed in both jejunum and enterocytes.
-Actin gene expression was used to normalize the amount of cDNA and results are expressed as fold change in mRNA
expression SEM comparing standardized amounts of cDNA corresponding to sensitized and treated mice with that in sensitized,
but untreated, mice. Results are representative of three independent experiments. (c) Balb/c mice were sensitized as shown in
the schematic drawing of the experimental protocol (control groups are included). (d) Clinical scores of mice 30–60 min following
the oral challenge with CMP; each point represents an individual mouse (see Table 1). (e) Serum level of CMP-specific IgE during
sensitization and treatment with G. bronchialis. (f) IL-5 and IFN-g concentration in supernatants of spleen cells collected 24 h following
the oral challenge and activated in vitro with 350mg/ml of CMP for 72 h. (g) mRNA expression for cytokines (IL-5 and IFN-) and
transcription factors (T-bet and GATA-3) was quantified in jejunum 24 h following the oral challenge. Results correspond to two
independent experiments with eight animals per group. *P< 0.05, **P< 0.01, ***P< 0.005.
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could have a role in controlling inflammation in the
colonic mucosa.
We also included in our work CT as a potent muco-
sal adjuvant that abrogates oral tolerance. It has been
demonstrated in mice that in CT-driven inflammation
the innate mediators IL-133 and CCL2034 are up-regu-
lated, followed by a Th2-biased adaptive immune
response that mimics the effector phase of a food
allergy.17,35 In the IgE-mediated food allergy mouse
model we found that the orally administered dead
G. bronchialis reversed the up-regulated mucosal
CCL20 gene transcription in the whole tissue and, par-
ticularly, in IEC. Furthermore, the oral administration
of dead G. bronchialis down-regulated the production
of the Th2-associated IgE Ab isotype, the signature
cytokine secretion, the gene expression of CCL20,
IL-5 and GATA-3 at the mucosal site and, most import-
antly, the symptoms associated with hypersensitivity
reactions in sensitized mice. No evidence of Th1
immune response induction was found. It has been
demonstrated in asthma mouse models that other
Actinomycetales genera induce Treg, which, in turn,
reverts the allergic status of mice.36 This mechanism
needs to be explored in our food allergy model.
Several studies have focused on the potential use of
these Actinomycetales bacteria in anti-inflammatory
interventions. However, few data are available on intes-
tinal models and here we provide evidence that dead
G. bronchialis exerts a mucosal modulation upon
administration of flagellin and CT.
Conclusions
Our results demonstrate that dead G. bronchialis bac-
teria inhibit the TNF-a-, IL-1b- or flagellin-induced
NF-kB activation, and CCL20 gene transcription in
human ECs and in mouse intestine. We demonstrated
that bacteria induced the production of ROS, which
impairs the translocation of p65 into the nucleus
and further gene expression of cytokines and chemo-
kines. We also used this bacterium through the oral
route to control the allergic reaction and mucosal
inflammation in a food allergy mouse model. The
inhibitory effect promoted by G. bronchialis might
have potential applications in therapeutic strategies
attempting to control innate immunity in inflammatory
intestinal disorders.
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